NEW YORK (360Dx) – March was another down month for many diagnostics firms' stocks as the 360Dx Index slumped more than 3 percent month over month.

The index's March doldrums followed a slow February when it was down 3 percent compared to January. Of the 25 firms in the index, 17 saw their shares fall last month, paced by Invitae (-29 percent), Enzo Biochem (-13 percent), and Accelerate Diagnostics (-13 percent). GenMark Diagnostics led the gainers (+32 percent), followed by Quidel (+19 percent), and Oxford Immunotec (+14 percent).

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.